MariMed Inc. (OTCMKTS:MRMD - Free Report) - Investment analysts at Ventum Cap Mkts issued their FY2026 earnings estimates for shares of MariMed in a research note issued to investors on Thursday, November 7th. Ventum Cap Mkts analyst A. Semple anticipates that the company will post earnings per share of $0.00 for the year. Ventum Cap Mkts currently has a "Strong-Buy" rating on the stock.
MariMed Stock Performance
MRMD traded down $0.02 on Monday, hitting $0.15. The company's stock had a trading volume of 813,969 shares, compared to its average volume of 450,431. MariMed has a 12 month low of $0.14 and a 12 month high of $0.39. The firm has a market cap of $55.15 million, a P/E ratio of -5.45 and a beta of 2.80. The company has a quick ratio of 0.73, a current ratio of 1.55 and a debt-to-equity ratio of 1.01. The company's 50 day simple moving average is $0.16 and its 200-day simple moving average is $0.19.
About MariMed
(
Get Free Report)
MariMed Inc engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature's Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; and drink mix under Vibations brand.
Further Reading
Before you consider MariMed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MariMed wasn't on the list.
While MariMed currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for November 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
